| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cortexyme, Inc. | Interim CEO, COO & CFO | Common Stock | 265,000 | $249,100 | $0.9400 | 03 Mar 2022 | Direct |
| Vincerx Pharma, Inc. | Director | Common Stock | 40,000 | $37,972 | $0.9493 | 25 Aug 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VINC | Vincerx Pharma, Inc. | 24 Aug 2022 | 2 | +$49,438 | 4 | Director | 26 Aug 2022, 16:06 |
| VINC | Vincerx Pharma, Inc. | 26 May 2022 | 1 | $0 | 4 | Director | 31 May 2022, 16:06 |
| QNCX | Cortexyme, Inc. | 03 Mar 2022 | 1 | $0 | 4 | Interim CEO, COO & CFO | 04 Mar 2022, 16:55 |
| QNCX | Cortexyme, Inc. | 03 Jan 2022 | 1 | $0 | 4 | COO & Chief Financial Officer | 05 Jan 2022, 16:05 |
| QNCX | Cortexyme, Inc. | 16 Nov 2021 | 2 | +$66,900 | 4 | COO & Chief Financial Officer | 16 Nov 2021, 19:17 |
| QNCX | Cortexyme, Inc. | 05 Oct 2021 | 3 | -$216,635 | 4 | COO & Chief Financial Officer | 07 Oct 2021, 18:24 |
| QNCX | Cortexyme, Inc. | 16 Aug 2021 | 9 | -$1,980,819 | 4 | COO & Chief Financial Officer | 18 Aug 2021, 17:25 |
| VINC | Vincerx Pharma, Inc. | 29 Jun 2021 | 2 | +$126,152 | 4 | Director | 30 Jun 2021, 18:59 |
| QNCX | Cortexyme, Inc. | 28 Jun 2021 | 8 | -$971,574 | 4 | COO & Chief Financial Officer | 30 Jun 2021, 17:46 |
| VINC | Vincerx Pharma, Inc. | 13 May 2021 | 1 | $0 | 4 | Director | 14 May 2021, 17:23 |